Term
|
Definition
| highly emetogenic, ototoxic, and renal toxic Platinum Agent |
|
|
Term
|
Definition
| highly emetogenic and renal toxic Platinum Agent (use calvert formula dosing) |
|
|
Term
|
Definition
| Platinum agent not used in lung cancer, mostly in colon |
|
|
Term
|
Definition
| Taxane agent, moderate to low emetogenic potential, can be neurotoxic |
|
|
Term
|
Definition
| Taxane agent that is better tolerated than Paclitaxel |
|
|
Term
|
Definition
| Mildly emetogenic, severe hypotension with rapid infusion |
|
|
Term
| Vinblastine and Vinorelbine |
|
Definition
| Neurotoxic, vinca alkaloid-- *fatal if administered intrathecally!! |
|
|
Term
|
Definition
| Tyrosine kinase inhibitor: Improves OS by 3.3 months, 2nd or 3rd line |
|
|
Term
|
Definition
| Tyrosine kinase inhibitor: Used to terat NSCLC that is advanced or metastasis and is caused by a defect in gene called ALK |
|
|
Term
|
Definition
| used in combo with chemo as first line therapy in advanced NSCLC |
|
|
Term
|
Definition
| one of the agents that can be used in combo with Cisplatin or Carboplatin in 1st line therapy in advanced NSCLC |
|
|
Term
|
Definition
| one of the agents that can be used in combo with Cisplatin or Carboplatin in 1st line therapy in advanced NSCLC |
|
|
Term
|
Definition
| an agent that can be used as second line therapy in advanced NSCLC |
|
|
Term
|
Definition
| Data encouraging for extensive stage disease in SCLC but needs to be confirmed in US studies |
|
|
Term
| Cisplatin with pemetrexed |
|
Definition
| treatment in Mesothelioma |
|
|
Term
| Folic acid, Vitamin B12, Dexamethasone |
|
Definition
| Adjuvant meds necessary for pemetrexed |
|
|
